Nicolas Ansermot

7PUBLICATIONS
16CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersMetabolic medicineClinical pharmacology and therapeuticsForensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2026
Psychotropic drug-induced weight gain and untargeted metabolomics: machine learning-driven results from a prospective cohort study.

|Sep 17, 2025
Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses.

Nermine Laaboub, Frederik Vandenberghe, Nicolas Ansermot

|May 26, 2025
Metabolic syndrome and its components are associated with lengths of stay in a psychiatric hospital: Results from a Swiss psychiatric cohort and first-episode psychosis patients.

Nermine Laaboub, Setareh Ranjbar, Séverine Crettol

|May 12, 2025
Cytochrome P450 2D6 Poor Metabolizers and Risperidone Treatment Failure: A 1-Year Longitudinal Study.

Marianna Piras, Setareh Ranjbar, Séverine Crettol

|Jun 04, 2024
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric Patients.

Nicolas Ansermot, Harish Vathanarasa, Setareh Ranjbar

|Feb 09, 2022
Psychotropic Drug Prescription in Children and Adolescents: Approved Medications in European Countries and the United States.

Michal Smogur, Alice Onesanu, Kerstin Jessica Plessen

Pageof 2

Frequent Collaborators

4 joint publications

Chin Bin Eap

4 joint publications

Marianna Piras

4 joint publications

Séverine Crettol

3 joint publications

Frederik Vandenberghe